Bluejay | Investor Presentation Deck | 20 slides

Bluejay Diagnostics · 2023-12

arc beats above · slides in the middle · loops below · scroll → 3 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 11 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 11 hits

— 0/2 slides

100% 2/2 slides 100% 2/2 slides · 3 hits 100% 2/2 slides Agitate 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 39 hits

— 0/6 slides

16.7% 1/6 slides 66.7% 4/6 slides 100% 6/6 slides 100% 6/6 slides · 8 hits Market Sizing 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Financial Highlights 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides

— 0/1 slides

Slide inventory

every slide · same image gating as the playbook

front_matter

Open slide detail

other

Open slide detail

The slide uses a structured list format to present key company pillars.summarize

Open slide detail

Uses a two-column comparison for Sepsis vs Septic Shock, followed by two rows of key metrics.frame_problem

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide uses a process flow diagram to contrast time-to-diagnosis and a bar chart to illustrate the exponential mortality risk of delayed treatment.frame_problem

Open slide detailBeat · ProblemLoop · Cost Of Inaction

Uses a before-after-bridge framing to contrast current lab processes with the proposed solution.present_solution

Open slide detailBeat · SolutionLoop · Golden Circle

The slide uses a two-column layout to contrast the platform hardware with the consumable cartridges.present_solution

Open slide detailBeat · SolutionLoop · Golden Circle

The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solframe_problem

Open slide detailBeat · SolutionLoop · Golden Circle

The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.compare_peers

Open slide detailBeat · SolutionLoop · Golden Circle

The slide uses a horizontal bar chart to represent progress through Research, Development, Clinical Testing, and Regulatory stages.plan_implementation

Open slide detailBeat · SolutionLoop · Golden Circle

The slide emphasizes the clinical value of rapid turnaround time in critical care settings.present_solution

Open slide detailBeat · SolutionLoop · Golden Circle

Includes a specific capital requirement estimate at the bottom.plan_implementation

Open slide detailLoop · Quick Win Big Bet

The slide uses a bottom-up market sizing approach based on patient volumes and testing frequency.size_opportunity

Open slide detailBeat · Market SizingLoop · Quick Win Big Bet

The table compares 7 distinct operational metrics between the Bluejay Symphony and competitors (Beckman, Siemens, Roche).compare_peers

Open slide detail

Uses a stepped growth diagram to illustrate the commercialization roadmap.plan_implementation

Open slide detail

other

Open slide detail

other

Open slide detail

Includes both internal cash position and public market trading data for BJSX.analyze_data